Differential gene expression profile and altered cytokine secretion of thyroid cancer cells in space

FASEB Journal

Volumn 28, Issue 2, 2014, Pages 813-835

  Ma, Xiao ^a   Pietsch, Jessica ^b   Wehland, Markus ^b   Schulz, Herbert ^c   Saar, Katrin ^c   Hübner, Norbert ^c   Bauer, Johann ^d   Braun, Markus ^e   Schwarzwälder, Achim ^f   Segerer, Jürgen ^f   Birlem, Maria ^f   Horn, Astrid ^f   Hemmersbach, Ruth ^g   Waßer, Kai ^g   Grosse, Jirka ^h   Infanger, Manfred ^b   Grimm, Daniela ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^e UNIVERSITY OF BONN   (Germany)

^f AIRBUS GROUP INNOVATIONS   (Germany)

^g GERMAN AEROSPACE CENTER DLR   (Germany)

^h UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Extracellular matrix; Growth factors; Microgravity; Protein kinases

Indexed keywords

ACTIN BINDING LIM PROTEIN 1; ACTIVATING TRANSCRIPTION FACTOR 4; BCL 2 LIKE PROTEIN 12; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D2; CYCLIN E; CYTOCHROME C OXIDASE; CYTOKINE; FIBROBLAST GROWTH FACTOR 17; GELATINASE A; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; HEAT SHOCK PROTEIN 47; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 8; LIM PROTEIN; OSTEOPONTIN; PROTEIN; PROTEIN BCL 2; PROTEIN BCL 3; PROTEIN KINASE C; PROTEIN P21; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RNA 18S; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UBIQUINONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN A; VASCULOTROPIN D; PROTEIN KINASE;

ADULT; ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL ADHESION; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL RESPIRATION; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSKELETON; DEVICES; DNA REPAIR; ELECTRON TRANSPORT; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; MICROGRAVITY; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PARABOLIC FLIGHT CAMPAIGN; POORLY DIFFERENTIATED THYROID CANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; RANDOM POSITIONING MACHINE; SIGNAL TRANSDUCTION; SIMULATION; SPACE; SPACE FLIGHT; THYROID CANCER; THYROID CANCER CELL LINE; GENE EXPRESSION REGULATION; GENETICS; GROWTH FACTORS; METABOLISM; POLYMERASE CHAIN REACTION; THYROID TUMOR; TUMOR CELL LINE; WEIGHTLESSNESS;

EXTRACELLULAR MATRIX; GROWTH FACTORS; MICROGRAVITY; PROTEIN KINASES;

CELL LINE, TUMOR; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; SPACE FLIGHT; THYROID NEOPLASMS; WEIGHTLESSNESS;

EID: 84897066502     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-243287     Document Type: Article

References (98)

1. White, R. J., and Averner, M. (2001) Humans in space. Nature 409, 1115-1118
2. Hughes-Fulford, M. (2011) To infinity and beyond! Human spaceflight and life science. FASEB J. 25, 2858-2864
3. Grimm, D., Wise, P., Lebert, M., Richter, P., and Baatout, S. (2011) How and why does the proteome respond to microgravity? Expert Rev. Proteomics 8, 13-27
4. Pietsch, J., Bauer, J., Egli, M., Infanger, M., Wise, P., Ulbrich, C., and Grimm, D. (2011) The effects of weightlessness on the human organism and mammalian cells. Curr. Mol. Med. 11, 350-364
5. Cogoli, A., Tschopp, A., and Fuchs-Bislin, P. (1984) Cell sensitivity to gravity. Science 225, 228-230
6. Kossmehl, P., Shakibaei, M., Cogoli, A., Infanger, M., Curcio, F., Schönberger, J., Eilles, C., Bauer, J., Pickenhahn, H., Schulze- Tanzil, G., Paul, M., and Grimm, D. (2003) Weightlessness induced apoptosis in normal thyroid cells and papillary thyroid carcinoma cells via extrinsic and intrinsic pathways. Endocrinology 144, 4172-4179
7. Lewis, M. L., Reynolds, J. L., Cubano, L. A., Hatton, J. P., Lawless, B. D., and Piepmeier, E. H. (1998) Spaceflight alters microtubules and increases apoptosis in human lymphocytes (Jurkat). FASEB J. 12, 1007-1018
8. Grimm, D., Bauer, J., Kossmehl, P., Shakibaei, M., Schonberger, J., Pickenhahn, H., Schulze-Tanzil, G., Vetter, R., Eilles, C., Paul, M., and Cogoli, A. (2002) Simulated microgravity alters differentiation and increases apoptosis in human follicular thyroid carcinoma cells. FASEB J. 16, 604-606
9. Grosse, J., Wehland, M., Pietsch, J., Schulz, H., Saar, K., Hübner, N., Eilles, C., Bauer, J., Abou-El-Ardat, K., Baatout, S., Ma, X., Infanger, M., Hemmersbach, R., and Grimm, D. (2012) Gravitysensitive signaling drives 3-dimensional formation of multicellular thyroid cancer spheroids. FASEB J. 26, 5124-5140
10. Durante, C., Haddy, N., Baudin, E., Leboulleux, S., Hartl, D., Travagli, J. P., Caillou, B., Ricard, M., Lumbroso, J. D., De Vathaire, F., and Schlumberger, M. (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 91, 2892-2899
11. Boonyaratanakornkit, J. B., Cogoli, A., Li, C. F., Schopper, T., Pippia, P., Galleri, G., Meloni, M. A., and Hughes-Fulford, M. (2005) Key gravity-sensitive signaling pathways drive T cell activation. FASEB J. 19, 2020-2022
12. Maccarrone, M., Battista, N., Meloni, M., Bari, M., Galleri, G., Pippia, P., Cogoli, A., and Finazzi-Agrò, A. (2003) Creating conditions similar to those that occur during exposure of cells to microgravity induces apoptosis in human lymphocytes by 5-lipoxygenase-mediated mitochondrial uncoupling and cytochrome c release. J. Leukoc. Biol. 73, 472-481
13. Uva, B. M., Masini, M. A., Sturla, M., Bruzzone, F., Giuliani, M., Tagliafierro, G., and Strollo, F. (2002) Microgravity-induced apoptosis in cultured glial cells. Eur. J. Histochem. 46, 209-214
14. Griffoni, C., Di Molfetta, S., Fantozzi, L., Zanetti, C., Pippia, P., Tomasi, V., and Spisni, E. (2011) Modification of proteins secreted by endothelial cells during modeled low gravity exposure. J. Cell. Biochem. 112, 265-272
15. Grimm, D., Bauer, J., Ulbrich, C., Westphal, K., Wehland, M., Infanger, M., Aleshcheva, G., Pietsch, J., Ghardi, M., Beck, M., El-Saghire, H., de Saint-Georges, L., and Baatout, S. (2010) Different responsiveness of endothelial cells to vascular endothelial growth factor and basic fibroblast growth factor added to culture media under gravity and simulated microgravity. Tissue Eng. A 16, 1559-1573
16. Grimm, D., Infanger, M., Westphal, K., Ulbrich, C., Pietsch, J., Kossmehl, P., Vadrucci, S., Baatout, S., Flick, B., Paul, M., and Bauer, J. (2009) A delayed type of three-dimensional growth of human endothelial cells under simulated weightlessness. Tissue Eng. A 15, 2267-2275
17. Pietsch, J., Kussian, R., Sickmann, A., Bauer, J., Weber, G., Nissum, M., Westphal, K., Egli, M., Grosse, J., Schönberger, J., Wildgruber, R., Infanger, M., and Grimm, D. (2010) Application of free-flow IEF to identify protein candidates changing under microgravity conditions. Proteomics 10, 904-913
18. Zeng, J., Xie, K., Wu, H., Zhang, B., and Huang, C. (2012) Identification and functional study of cytokines and chemokines involved in tumorigenesis. Comb. Chem. High Throughput Screen. 15, 276-285
19. Willett, C. G., Duda, D. G., di Tomaso, E., Boucher, Y., Ancukiewicz, M., Sahani, D. V., Lahdenranta, J., Chung, D. C., Fischman, A. J., Lauwers, G. Y., Shellito, P., Czito, B. G., Wong, T. Z., Paulson, E., Poleski, M., Vujaskovic, Z., Bentley, R., Chen, H. X., Clark, J. W., Jain, R. K. (2009) Efficacy, safety and biomarkers of neoadjuvant bevacizumab, radiation therapy and 5-fluorouracil in rectal cancer: a multidisciplinary phase II study. J. Clin. Oncol. 27, 3020-3026
20. Zhu, A. X., Sahani, D. V., Duda, D. G., di Tomaso, E., Ancukiewicz, M., Catalano, O. A., Sindhwani, V., Blaszkowsky, L. S., Yoon, S. S., Lahdenranta, J., Bhargava, P., Meyerhardt, J., Clark, J. W., Kwak, E. L., Hezel, A. F., Miksad, R., Abrams, T. A., Enzinger, P. C., Fuchs, C. S., Ryan, D. P., and Jain, R. K. (2009) Efficacy, safety and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J. Clin. Oncol. 27, 3027-3035
21. Ning, Y., Manegold, P. C., Hong, Y. K., Zhang, W., Pohl, A., Lurje, G., Winder, T., Yang, D., LaBonte, M. J., Wilson, P. M., Ladner, R. D., and Lenz, H. J. (2011) Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer 128, 2038-2049
22. Xie, K. (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 12, 375-391
23. Grosse, J., Wehland, M., Pietsch, J., Ma, X., Ulbrich, C., Schulz, H., Saar, K., Hübner, N., Hauslage, J., Hemmersbach, R., Braun, M., van Loon, J., Vagt, N., Infanger, M., Eilles, C., Egli, M., Richter, P., Baltz, T., Einspanier, R., Sharbati, S., and Grimm, D. (2012) Short-term weightlessness produced by parabolic flight maneuvers altered gene expression patterns in human endothelial cells. FASEB J. 26, 639-655
24. Ulbrich, C., Pietsch, J., Grosse, J., Wehland, M., Schulz, H., Saar, K., Hübner, N., Hauslage, J., Hemmersbach, R., Braun, M., van Loon, J., Vagt, N., Egli, M., Richter, P., Einspanier, R., Sharbati, S., Baltz, T., Infanger, M., Ma, X., and Grimm, D. (2011) Differential gene regulation under altered gravity conditions in follicular thyroid cancer cells: relationship between the extracellular matrix and the cytoskeleton. Cell. Physiol. Biochem. 28, 185-198
25. Pietsch, J., Ma, X., Wehland, M., Aleshcheva, G., Schwarzwälder, A., Segerer, J., Birlem, M., Horn, A., Bauer, J., Infanger, M., and Grimm, D. (2013) Spheroid formation of human thyroid cancer cells in an automated culturing system during the Shenzhou-8 space mission. Biomaterials 34, 7694-7705
26. Hoelting, T., Duh, Q. Y., Clark, O. H., and Herfarth, C. (1997) Invasion of metastatic human follicular thyroid cancer is inhibited via antagonism of protein kinase C. Cancer Lett. 119, 1-5
27. Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., Mamer, O. A., Avizonis, D., DeBerardinis, R. J., Siegel, P. M., and Jones, R. G. (2013) AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 17, 113-124
28. Goretzki, P. E., Frilling, A., Simon, D., and Roeher, H. D. (1990) Growth regulation of normal thyroids and thyroid tumors in man. Recent Results Cancer Res. 118, 48-63
29. Van Loon, J. J. (2007) Some history and use of the random positioning machine, RPM, in gravity related research. Adv. Space Res. 39, 1161-1165
30. Ulbrich, C., Westphal, K., Pietsch, J., Winkler, H. D., Leder, A., Bauer, J., Kossmehl, P., Grosse, J., Schoenberger, J., Infanger, M., Egli, M., and Grimm, D. (2010) Characterization of human chondrocytes exposed to simulated microgravity. Cell. Physiol. Biochem. 25, 551-560
31. Ulbrich, C., Westphal, K., Baatout, S., Wehland, M., Bauer, J., Flick, B., Infanger, M., Kreutz, R., Vadrucci, S., Egli, M., Cogoli, A., Derradji, H., Pietsch, J., Paul, M., and Grimm, D. (2008) Effects of basic fibroblast growth factor on endothelial cells under conditions of simulated microgravity. J. Cell. Biochem. 104, 1324-1341
32. Kossmehl, P., Kurth, E., Faramarzi, S., Habighorst, B., Shakibaei, M., Wehland, M., Kreutz, R., Infanger, M., Danser, J. A. H., Grosse, J., Paul, M., and Grimm, D. (2006) Mechanisms of apoptosis after ischemia and reperfusion: role of the reninangiotensin system. Apoptosis 11, 347-358
33. Rothermund, L., Kreutz, R., Kossmehl, P., Fredersdorf, S., Shakibaei, M., Schulze-Tanzil, G., Paul, M., and Grimm, D. (2002) Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy. Am. J. Hypertens. 15, 644-652
34. Benjamini, Y., and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289-300
35. Reimand, J., Kull, M., Peterson, H., Hansen, J., and Vilo, J. (2007) g: Profiler: a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 35, W193-W200
36. Davies, D. L., and Bouldin, D. W. (1979) A clustering separation measure. IEEE Trans. PAMI 1, 224-227
37. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
38. Huang da, W., Sherman, B. T., and Lempicki, R. A. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13
39. Snel, B., Lehmann, G., Bork, P., and Huynen, M. A. (2000) STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res. 28, 3442-3444
40. Grosse, J., Warnke, E., Pohl, F., Magnusson, N. E., Wehland, M., Infanger, M., Eilles, C., and Grimm, D. (2013) Impact of sunitinib on human thyroid cancer cells. Cell. Physiol. Biochem. 32, 154-170
41. Huigsloot, M., Nijtmans, L. G., Szklarczyk, R., Baars, M. J., van den Brand, M. A., Hendriksfranssen, M. G., van den Heuvel, L. P., Smeitink, J. A., Huynen, M. A., and Rodenburg, R. J. (2011) A mutation in C2orf64 causes impaired cytochrome c oxidase assembly and mitochondrial cardiomyopathy. Am. J. Hum. Genet. 88, 488-493
42. Villagra, A., Ulloa, N., Zhang, X., Yuan, Z., Sotomayor, E., and Seto, E. (2007) Histone deacetylase 3 down-regulates cholesterol synthesis through repression of lanosterol synthase gene expression. J. Biol. Chem. 282, 35457-35470
43. Mori, M., Li, G., Abe, I., Nakayama, J., Guo, Z., Sawashita, J., Ugawa, T., Nishizono, S., Serikawa, T., Higuchi, K., and Shumiya, S. (2006) Lanosterol synthase mutations cause cholesterol deficiency-associated cataracts in the Shumiya cataract rat. J. Clin. Invest. 116, 395-404
44. Lee, Y. Y., Yu, Y. B., Gunawardena, H. P., Xie, L., and Chen, X. (2012) BCLAF1 is a radiation-induced H2AX-interacting partner involved in H2AX-mediated regulation of apoptosis and DNA repair. Cell Death Dis. 3, e359
45. Borst, A. G., and van Loon, J. (2009) Technology and developments for the random positioning machine, RPM. Microgravity Sci. Technol. 21, 287-292
46. Wehland, M., Ma, X., Braun, M., Hauslage, J., Hemmersbach, R., Bauer, J., Grosse, J., Infanger, M., and Grimm, D. (2013) The impact of altered gravity and vibration on endothelial cells during a parabolic flight. Cell. Physiol. Biochem. 31, 432-451
47. Grimm, D., Bauer, J., and Schoenberger, J. (2009) Blockade of neoangiogenesis: a new and promising technique to control the growth of malignant tumors and their metastases. Curr. Vasc. Pharmacol. 7, 347-357
48. Ferrara, N. (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581-611
49. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309
50. Infanger, M., Shakibaei, M., Kossmehl, P., Hollenberg, S. M., Grosse, J., Faramarzi, S., Schulze-Tanzil, G., Paul, M., and Grimm, D. (2005) Intraluminal application of vascular endothelial growth factor enhances healing of microvascular anastomosis in a rat model. J. Vasc. Res. 42, 202-213
51. Infanger, M., Schmidt, O., Kossmehl, P., Grad, S., Ertel, W., and Grimm, D. (2004) Vascular endothelial growth factor serum level is strongly enhanced after burn injury and correlated with local and general tissue edema. Burns 30, 305-311
52. Infanger, M., Grosse, J., Westphal, K., Leder, A., Ulbrich, C., Paul, M., and Grimm, D. (2008) Vascular endothelial growth factor induces extracellular matrix proteins and osteopontin in the umbilical artery. Ann. Vasc. Surg. 22, 273-284
53. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., and Keshet, E. (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1, 1024-1028
54. Hsueh, C., Lin, J. D., Wu, I. C., Chao, T. C., Yu, J. S., Liou, M. J., and Yeh, C. J. (2011) Vascular endothelial growth factors and angiopoietins in presentations and prognosis of papillary thyroid carcinoma. J. Surg. Oncol. 103, 395-359
55. Nersita, R., Matrone, A., Klain, M., Scavuzzo, F., Vitolo, G., Abbondanza, C., Carlino, M. V., Giacco, V., Amato, G., and Carella, C. (2012) Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinoma. Clin. Endocrinol. (Oxf.) 76, 142-146
56. Barry, M., and Bleackley, R. C. (2002) Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2, 401-409
57. Zhang, M., Yao, Z., Dubois, S., Ju, W., Müller, J. R., and Waldmann, T. A. (2009) Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer Proc. Natl. Acad. Sci. U. S. A. 106, 7513-7518
58. Kimura, K., Nishimura, H., Matsuzaki, T., Yokokura, T., Nimura, Y., and Yoshikai, Y. (2000) Synergistic effect of interleukin-15 and interleukin-12 on antitumor activity in a murine malignant pleurisy model. Cancer Immunol. Immunother. 49, 71-77
59. Basak, G. W., Zapala, L., Wysocki, P. J., Mackiewicz, A., Jakóbisiak, M., and Lasek, W. (2008) Interleukin 15 augments antitumor activity of cytokine gene-modified melanoma cell vaccines in a murine model. Oncol. Rep. 19, 1173-1179
60. Yu, P., Steel, J. C., Zhang, M., Morris, J. C., and Waldmann, T. A. (2010) Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by interleukin-15 in a murine metastatic colon carcinoma model. Clin. Cancer Res. 16, 6019-6028
61. Grenon, S. M., Jeanne, M., Aguado-Zuniga, J., Conte, M. S., and Hughes-Fulford, M. (2013) Effects of gravitational mechanical unloading in endothelial cells: association between caveolins, inflammation and adhesion molecules. Sci. Rep. 3, 1494
62. Ornitz, D. M., and Itoh, N. (2001) Fibroblast growth factors. Genome Biol. 2, REVIEWS3005
63. Klagsbrun, M. (1989) The fibroblast growth factor family: structural and biological properties. Prog. Growth Factor Res. 1, 207-235
64. Basilico, C., and Moscatelli, D. (1992) The FGF family of growth factors and oncogenes. Adv. Cancer Res. 59, 115-165
65. Maruoka, Y., Ohbayashi, N., Hoshikawa, M., Itoh, N., Hogan, B. L., and Furuta, Y. (1998) Comparison of the expression of three highly related genes, Fgf8, Fgf17 and Fgf18, in the mouse embryo. Mech. Dev. 74, 175-177
66. Xu, J., Liu, Z., and Ornitz, D. M. (2000) Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures. Development 127, 1833-1843
67. Xu, J., Lawshe, A., MacArthur, C. A., and Ornitz, D. M. (1999) Genomic structure, mapping, activity and expression of fibroblast growth factor 17. Mech. Dev. 83, 165-178
68. Heer, R., Douglas, D., Mathers, M. E., Robson, C. N., and Leung, H. Y. (2004) Fibroblast growth factor 17 is over-expressed in human prostate cancer J. Pathol. 204, 5785-5786
69. Gauglhofer, C., Sagmeister, S., Schrottmaier, W., Fischer, C., Rodgarkia-Dara, C., Mohr, T., Stättner, S., Bichler, C., Kandioler, D., Wrba, F., Schulte-Hermann, R., Holzmann, K., Grusch, M., Marian, B., Berger, W., and Grasl-Kraupp, B. (2011) Upregulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis. Hepatology 53, 854-864
70. Giachelli, C. M., and Steitz, S. (2000) Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol. 19, 615-622
71. Castellone, M. D., Celetti, A., Guarino, V., Cirafici, A. M., Basolo, F., Giannini, R., Medico, E., Kruhoffer, M., Orntoft, T. F., Curcio, F., Fusco, A., Melillo, R. M., and Santoro, M. (2004) Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/ PTC-transformed thyroid cells. Oncogene 23, 2188-2196
72. Guarino, V., Faviana, P., Salvatore, G., Castellone, M. D., Cirafici, A. M., De Falco, V., Celetti, A., Giannini, R., Basolo, F., Melillo, R. M., and Santoro, M. (2005) Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. J. Clin. Endocrinol. Metab. 90, 5270-5278
73. Briese, J., Cheng, S., Ezzat, S., Liu, W., Winer, D., Wagener, C., Bamberger, A. M., and Asa, S. L. (2010) Osteopontin (OPN) expression in thyroid carcinoma. Anticancer Res. 30, 1681-1688
74. Rollins, B. J. (2006) Inflammatory chemokines in cancer growth and progression. Eur. J. Cancer 42, 760-767
75. Murooka, T. T., Ward, S. E., and Fish, E. N. (2005) Chemokines and cancer. Cancer Treat. Res. 126, 15-44
76. Zlotnik, A. (2006) Chemokines and cancer. Int. J. Cancer 119, 2026-2029
77. Levina, V., Nolen, B. M., Marrangoni, A. M., Cheng, P., Marks, J. R., Szczepanski, M. J., Szajnik, M. E., Gorelik, E., and Lokshin, A. E. (2009) Role of eotaxin-1 signaling in ovarian cancer. Clin. Cancer Res. 15, 2647-2656
78. Agarwal, M., He, C., Siddiqui, J., Wei, J. T., and Macoska, J. A. (2013) CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancer. Prostate 73, 573-581
79. Chakraborty, S., Kaur, S., Guha, S., and Batra, S. K. (2012) The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. Biochim. Biophys. Acta 1826, 129-169
80. Iannetti, A., Pacifico, F., Acquaviva, R., Lavorgna, A., Crescenzi, E., Vascotto, C., Tell, G., Salzano, A. M., Scaloni, A., Vuttariello, E., Chiappetta, G., Formisano, S., and Leonardi, A. (2008) The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB- regulated gene, is a survival factor for thyroid neoplastic cells. Proc. Natl. Acad. Sci. U. S. A. 105, 14058-14063
81. Volpe, V., Raia, Z., Sanguigno, L., Somma, D., Mastrovito, P., Moscato, F., Mellone, S., Leonardi, A., and Pacifico, F. (2013) NGAL controls the metastatic potential of anaplastic thyroid carcinoma cells. J. Clin. Endocrinol. Metab. 98, 228-235
82. Marastoni, S., Ligresti, G., Lorenzon, E., Colombatti, A., and Mongiat, M. (2008) Extracellular matrix: a matter of life and death. Connect. Tissue Res. 49, 203-206
83. Visse, R., and Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839
84. Gomez, D. E., Alonso, D. F., Yoshiji, H., and Thorgeirsson, U. P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74, 111-122
85. Kraiem, Z., and Korem, S. (2000) Matrix metalloproteinases and the thyroid. Thyroid 10, 1061-1069
86. Zou, Z., Anisowicz, A., Hendrix, M. J., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., and Sager, R. (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263, 526-529
87. Pemberton, P. A., Tipton, A. R., Pavloff, N., Smith, J., Erickson, J. R., Mouchabeck, Z. M., and Kiefer, M. C. (1997) Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface. J. Histochem. Cytochem. 45, 1697-1706
88. Bailey, C. M., Khalkhali-Ellis, Z., Seftor, E. A., Hendrix, M. J. (2006) Biological functions of maspin. J. Cell. Physiol. 209, 617-624
89. Antonelli, A., Ferrari, S. M., Fallahi, P., Frascerra, S., Piaggi, S., Gelmini, S., Lupi, C., Minuto, M., Berti, P., Benvenga, S., Basolo, F., Orlando, C., and Miccoli, P. (2009) Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor- gamma agonists. Endocr. Relat. Cancer 16, 1299-1311
90. Liaudet-Coopman, E., Beaujouin, M., Derocq, D., Garcia, M., Glondu-Lassis, M., Laurent-Matha, V., Prébois, C., Rochefort, H., and Vignon, F. (2006) Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis. Cancer Lett. 237, 1671-1679
91. Belbin, T. J., Singh, B., Smith, R. V., Socci, N. D., Wreesmann, V. B., Sanchez-Carbayo, M., Masterson, J., Patel, S., Cordon- Cardo, C., Prystowsky, M. B., and Childs, G. (2005) Molecular profiling of tumor progression in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 131, 10-18
92. Sarrió, D., Rodríguez-Pinilla, S. M., Dotor, A., Calero, F., Hardisson, D., and Palacios, J. (2006) Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res. Treat. 98, 71-79
93. Cui, Y., Wu, J., Zong, M., Song, G., Jia, Q., Jiang, J., and Han, J. (2009) Proteomic profiling in pancreatic cancer with and without lymph node metastasis. Int. J. Cancer 124, 1614-1621
94. Elliott, B. E., Meens, J. A., SenGupta, S. K., Louvard, D., and Arpin, M. (2005) The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res. 7, R365-R373
95. Cornford, P., Evans, J., Dodson, A., Parsons, K., Woolfenden, A., Neoptolemos, J., and Foster, C. S. (1999) Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer Am. J. Pathol. 154, 137-144
96. La Porta, C. A., and Comolli, R. (1997) Activation of protein kinase C-alpha isoform in murine melanoma cells with high metastatic potential. Clin. Exp. Metastasis 15, 568-579
97. Jeon, S. M., Chandel, N. S., and Hay, N. (2012) AMPK regulates NADPH homeostasis to promote tumor cell survival during energy stress. Nature 485, 661-665
98. Liang, J., and Mills, G. B. (2013) AMPK: a contextual oncogene or tumor suppressor? Cancer Res. 73, 2929-2935